Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and Alphabet, according to the Financial Times. The AI-first drug design and ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Google DeepMind CEO Demis Hassabis envisions AI eradicating all diseases within a decade, potentially revolutionizing drug ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Scientists have found a surprising new way to make certain cancer drugs work dramatically better – by helping them get inside ...

Researchers at Duke University School of Medicine hack cell entry to supercharge cancer drugs: Durham, North Carolina Monday, April 21, 2025, 17:00 Hrs [IST] A new discovery could ...

Structural insights from this work offer a roadmap for future drug developers to better evaluate drug interactions ... SCM-08 may serve as a key launching point to design even more selective CYP3A4 ...

April 17, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics ... Dr. Storgard brings over two decades of leadership and hands-on drug development experience, having successfully advanced multiple ...